Prostate Cancer Trial, Recruiting NCT05328505 Sponsor: University Health Network, Toronto Condition: Prostate Cancer
Back to Prostate Cancer

Prostate Cancer Trial, Recruiting

NCT05328505
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Men aged over 18 years old.
  • People with a confirmed diagnosis of prostate adenocarcinoma (a specific type of prostate cancer) proven through tissue testing.
  • People who have previously had their prostate removed through surgery (radical prostatectomy).
  • People whose cancer has shown signs of returning, with the recurrence identified in the local or nearby lymph node area through a PSMA PET scan (a specialised imaging test).
  • People who have five or fewer affected lymph nodes showing on the PSMA PET scan.
  • People with a good general health and activity level, as measured by a standard medical scale called ECOG, rated at 0 or 1 (meaning fully active or able to carry out light activities).

Who may not be able to join:

  • People who have cancer spread to lymph nodes near the main abdominal artery (para-aortic nodes) or to distant parts of the body.
  • People with a long-term inflammatory condition affecting the pelvic area.
  • People for whom radiation treatment would not be considered safe for medical reasons (confirm with trial site).
  • People who have previously received radiation treatment to the pelvic area.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 416-946-4501

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
23 August 2022
Est. completion
1 August 2028

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Grade ≥2 Toxicity for GU

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov